Amneal to buy Actavis’ Australian generics

Amneal Pharmaceuticals and Actavis Australia, a subsidiary of Actavis plc today announced they have signed a binding letter of intent which provides that Amneal intends to acquire substantially all of Actavis’ in-country generic pharmaceuticals business for an agreed price, subject to completion of confirmatory due diligence and definitive agreements. Financial terms of the agreement are